805 Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours

• Mark Lythgoe,
• Jonathan Krell,
• Axel Glasmacher,
• Justin Stebbing,
• Emily Pickford,
• Marsilio Adriani,
• Gayle Fyvie,
• Adam Frampton,
• Alex Stevenson

Affiliations

Mark Lythgoe

1Imperial College London, London, UK

Jonathan Krell

1Imperial College London, London, UK

Axel Glasmacher

24D pharma plc, Leeds, UK

Justin Stebbing

1Imperial College London, London, UK

Emily Pickford

1Imperial College London, London, UK

Marsilio Adriani

24D pharma plc, Leeds, UK

Gayle Fyvie

24D pharma plc, Leeds, UK

Adam Frampton

1Imperial College London, London, UK

Alex Stevenson

24D pharma plc, Leeds, UK